Cargando…
Loss of miR-637 promotes cancer cell stemness via WASH/IL-8 pathway and serves as a novel prognostic marker in esophageal squamous cell carcinoma
BACKGROUND: Esophageal carcinoma is the highly lethal cancer in the world, predominantly in some areas of East Asia. We previously reported that overexpression of cytoskeleton regulator Wiskott-Aldrich syndrome protein and SCAR Homolog (WASH) associates with poor prognosis of patients with esophagea...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635169/ https://www.ncbi.nlm.nih.gov/pubmed/36329557 http://dx.doi.org/10.1186/s40364-022-00424-x |
_version_ | 1784824651500748800 |
---|---|
author | Guo, Mengxing Lian, Jingyao Liu, Yaqing Dong, Bo He, Qianyi Zhao, Qitai Zhang, Hongyan Qi, Yu Zhang, Yi Huang, Lan |
author_facet | Guo, Mengxing Lian, Jingyao Liu, Yaqing Dong, Bo He, Qianyi Zhao, Qitai Zhang, Hongyan Qi, Yu Zhang, Yi Huang, Lan |
author_sort | Guo, Mengxing |
collection | PubMed |
description | BACKGROUND: Esophageal carcinoma is the highly lethal cancer in the world, predominantly in some areas of East Asia. We previously reported that overexpression of cytoskeleton regulator Wiskott-Aldrich syndrome protein and SCAR Homolog (WASH) associates with poor prognosis of patients with esophageal squamous cell carcinoma (ESCC). However, the molecular mechanism and clinical significance involved in WASH overexpression have not been fully elucidated. METHODS: Bioinformatics analysis and luciferase reporter assay were used to predict and validate miR-637 as a regulator of WASH in ESCC cell lines. qRT-PCR, Western blotting and ELISA assays were performed to examine RNA expression and protein levels, respectively. Next, the biological functions of miR-637 were explored by tumor sphere formation assay in vitro and nude mouse tumor xenograft in vivo. Finally, we evaluated the association of miR-637 levels with clinical features in ESCC patients. RESULTS: We identified miR-637 as a WASH-targeting miRNA. miR-637 mimic strongly attenuated the downstream IL-8 production and tumor sphere formation in esophageal cancer cells, whereas miR-637 inhibitor displayed an opposite effect. IL-8 could facilitate stem-like properties and partially rescue the phenotypes induced by miR-637 mimic. Furthermore, miR-637 inhibitor dramatically promoted IL-8 expression and cancer stemness properties in a WASH-dependent manner. Ectopic expression of miR-637 also inhibited tumor growth in a mouse model. Clinically, low expression of miR-637 was observed in tumor tissues and the low expression levels of miR-637 were correlated with poor survival of ESCC patients. In particular, plasma miR-637 could be used as a noninvasive biomarker for ESCC patients. CONCLUSIONS: These results implicate the potential application of miR-637 for diagnosis and prognosis of esophageal cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40364-022-00424-x. |
format | Online Article Text |
id | pubmed-9635169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96351692022-11-05 Loss of miR-637 promotes cancer cell stemness via WASH/IL-8 pathway and serves as a novel prognostic marker in esophageal squamous cell carcinoma Guo, Mengxing Lian, Jingyao Liu, Yaqing Dong, Bo He, Qianyi Zhao, Qitai Zhang, Hongyan Qi, Yu Zhang, Yi Huang, Lan Biomark Res Research BACKGROUND: Esophageal carcinoma is the highly lethal cancer in the world, predominantly in some areas of East Asia. We previously reported that overexpression of cytoskeleton regulator Wiskott-Aldrich syndrome protein and SCAR Homolog (WASH) associates with poor prognosis of patients with esophageal squamous cell carcinoma (ESCC). However, the molecular mechanism and clinical significance involved in WASH overexpression have not been fully elucidated. METHODS: Bioinformatics analysis and luciferase reporter assay were used to predict and validate miR-637 as a regulator of WASH in ESCC cell lines. qRT-PCR, Western blotting and ELISA assays were performed to examine RNA expression and protein levels, respectively. Next, the biological functions of miR-637 were explored by tumor sphere formation assay in vitro and nude mouse tumor xenograft in vivo. Finally, we evaluated the association of miR-637 levels with clinical features in ESCC patients. RESULTS: We identified miR-637 as a WASH-targeting miRNA. miR-637 mimic strongly attenuated the downstream IL-8 production and tumor sphere formation in esophageal cancer cells, whereas miR-637 inhibitor displayed an opposite effect. IL-8 could facilitate stem-like properties and partially rescue the phenotypes induced by miR-637 mimic. Furthermore, miR-637 inhibitor dramatically promoted IL-8 expression and cancer stemness properties in a WASH-dependent manner. Ectopic expression of miR-637 also inhibited tumor growth in a mouse model. Clinically, low expression of miR-637 was observed in tumor tissues and the low expression levels of miR-637 were correlated with poor survival of ESCC patients. In particular, plasma miR-637 could be used as a noninvasive biomarker for ESCC patients. CONCLUSIONS: These results implicate the potential application of miR-637 for diagnosis and prognosis of esophageal cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40364-022-00424-x. BioMed Central 2022-11-03 /pmc/articles/PMC9635169/ /pubmed/36329557 http://dx.doi.org/10.1186/s40364-022-00424-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Guo, Mengxing Lian, Jingyao Liu, Yaqing Dong, Bo He, Qianyi Zhao, Qitai Zhang, Hongyan Qi, Yu Zhang, Yi Huang, Lan Loss of miR-637 promotes cancer cell stemness via WASH/IL-8 pathway and serves as a novel prognostic marker in esophageal squamous cell carcinoma |
title | Loss of miR-637 promotes cancer cell stemness via WASH/IL-8 pathway and serves as a novel prognostic marker in esophageal squamous cell carcinoma |
title_full | Loss of miR-637 promotes cancer cell stemness via WASH/IL-8 pathway and serves as a novel prognostic marker in esophageal squamous cell carcinoma |
title_fullStr | Loss of miR-637 promotes cancer cell stemness via WASH/IL-8 pathway and serves as a novel prognostic marker in esophageal squamous cell carcinoma |
title_full_unstemmed | Loss of miR-637 promotes cancer cell stemness via WASH/IL-8 pathway and serves as a novel prognostic marker in esophageal squamous cell carcinoma |
title_short | Loss of miR-637 promotes cancer cell stemness via WASH/IL-8 pathway and serves as a novel prognostic marker in esophageal squamous cell carcinoma |
title_sort | loss of mir-637 promotes cancer cell stemness via wash/il-8 pathway and serves as a novel prognostic marker in esophageal squamous cell carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635169/ https://www.ncbi.nlm.nih.gov/pubmed/36329557 http://dx.doi.org/10.1186/s40364-022-00424-x |
work_keys_str_mv | AT guomengxing lossofmir637promotescancercellstemnessviawashil8pathwayandservesasanovelprognosticmarkerinesophagealsquamouscellcarcinoma AT lianjingyao lossofmir637promotescancercellstemnessviawashil8pathwayandservesasanovelprognosticmarkerinesophagealsquamouscellcarcinoma AT liuyaqing lossofmir637promotescancercellstemnessviawashil8pathwayandservesasanovelprognosticmarkerinesophagealsquamouscellcarcinoma AT dongbo lossofmir637promotescancercellstemnessviawashil8pathwayandservesasanovelprognosticmarkerinesophagealsquamouscellcarcinoma AT heqianyi lossofmir637promotescancercellstemnessviawashil8pathwayandservesasanovelprognosticmarkerinesophagealsquamouscellcarcinoma AT zhaoqitai lossofmir637promotescancercellstemnessviawashil8pathwayandservesasanovelprognosticmarkerinesophagealsquamouscellcarcinoma AT zhanghongyan lossofmir637promotescancercellstemnessviawashil8pathwayandservesasanovelprognosticmarkerinesophagealsquamouscellcarcinoma AT qiyu lossofmir637promotescancercellstemnessviawashil8pathwayandservesasanovelprognosticmarkerinesophagealsquamouscellcarcinoma AT zhangyi lossofmir637promotescancercellstemnessviawashil8pathwayandservesasanovelprognosticmarkerinesophagealsquamouscellcarcinoma AT huanglan lossofmir637promotescancercellstemnessviawashil8pathwayandservesasanovelprognosticmarkerinesophagealsquamouscellcarcinoma |